Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT01649284 |
Title | Afatinib Expanded Access Program |
Recruitment | Approved for marketing |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Boehringer Ingelheim |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
1200.45.004 Boehringer Ingelheim Investigational Site | Mobile | Alabama | United States | Details | ||
1200.45.116 Boehringer Ingelheim Investigational Site | Goodyear | Arizona | United States | Details | ||
1200.45.057 Boehringer Ingelheim Investigational Site | Hot Springs | Arkansas | United States | Details | ||
1200.45.078 Boehringer Ingelheim Investigational Site | Anaheim | California | United States | Details | ||
1200.45.114 Boehringer Ingelheim Investigational Site | Burbank | California | United States | Details | ||
1200.45.123 Boehringer Ingelheim Investigational Site | Glendale | California | United States | Details | ||
1200.45.115 Boehringer Ingelheim Investigational Site | Lakewood | California | United States | Details | ||
1200.45.117 Boehringer Ingelheim Investigational Site | Long Beach | California | United States | Details | ||
1200.45.102 Boehringer Ingelheim Investigational Site | Monterey | California | United States | Details | ||
1200.45.091 Boehringer Ingelheim Investigational Site | Pleasant Hill | California | United States | Details | ||
1200.45.098 Boehringer Ingelheim Investigational Site | Pleasant Hill | California | United States | Details | ||
1200.45.006 Boehringer Ingelheim Investigational Site | Ranco Cucamonga | California | United States | Details | ||
1200.45.003 Boehringer Ingelheim Investigational Site | Southington | Connecticut | United States | Details | ||
1200.45.007 Boehringer Ingelheim Investigational Site | Stamford | Connecticut | United States | Details | ||
1200.45.026 Boehringer Ingelheim Investigational Site | Hollywood | Florida | United States | Details | ||
1200.45.097 Boehringer Ingelheim Investigational Site | Hollywood | Florida | United States | Details | ||
1200.45.017 Boehringer Ingelheim Investigational Site | Jacksonville | Florida | United States | Details | ||
1200.45.058 Boehringer Ingelheim Investigational Site | Jacksonville | Florida | United States | Details | ||
1200.45.016 Boehringer Ingelheim Investigational Site | Lakeland | Florida | United States | Details | ||
1200.45.103 Boehringer Ingelheim Investigational Site | Miami Beach | Florida | United States | Details | ||
1200.45.037 Boehringer Ingelheim Investigational Site | Orlando | Florida | United States | Details | ||
1200.45.056 Boehringer Ingelheim Investigational Site | Port St. Lucie | Florida | United States | Details | ||
1200.45.119 Boehringer Ingelheim Investigational Site | Titusville | Florida | United States | Details | ||
1200.45.095 Boehringer Ingelheim Investigational Site | Alpharetta | Georgia | United States | Details | ||
1200.45.029 Boehringer Ingelheim Investigational Site | Athens | Georgia | United States | Details | ||
1200.45.042 Boehringer Ingelheim Investigational Site | Macon | Georgia | United States | Details | ||
1200.45.121 Boehringer Ingelheim Investigational Site | Valdosta | Georgia | United States | Details | ||
1200.45.024 Boehringer Ingelheim Investigational Site | Decatur | Illinois | United States | Details | ||
1200.45.009 Boehringer Ingelheim Investigational Site | Evanston | Illinois | United States | Details | ||
1200.45.099 Boehringer Ingelheim Investigational Site | Peoria | Illinois | United States | Details | ||
1200.45.040 Boehringer Ingelheim Investigational Site | Waterloo | Iowa | United States | Details | ||
1200.45.041 Boehringer Ingelheim Investigational Site | Wichita | Kansas | United States | Details | ||
1200.45.083 Boehringer Ingelheim Investigational Site | Marrero | Louisiana | United States | Details | ||
1200.45.087 Boehringer Ingelheim Investigational Site | Metairie | Louisiana | United States | Details | ||
1200.45.019 Boehringer Ingelheim Investigational Site | Columbia | Maryland | United States | Details | ||
1200.45.039 Boehringer Ingelheim Investigational Site | Rockville | Maryland | United States | Details | ||
1200.45.053 Boehringer Ingelheim Investigational Site | Ann Arbor | Michigan | United States | Details | ||
1200.45.046 Boehringer Ingelheim Investigational Site | Detroit | Michigan | United States | Details | ||
1200.45.100 Boehringer Ingelheim Investigational Site | Jackson | Mississippi | United States | Details | ||
1200.45.067 Boehringer Ingelheim Investigational Site | St. Louis | Missouri | United States | Details | ||
1200.45.071 Boehringer Ingelheim Investigational Site | Billings | Montana | United States | Details | ||
1200.45.021 Boehringer Ingelheim Investigational Site | Omaha | Nebraska | United States | Details | ||
1200.45.066 Boehringer Ingelheim Investigational Site | Freehold | New Jersey | United States | Details | ||
1200.45.105 Boehringer Ingelheim Investigational Site | Albuquerque | New Mexico | United States | Details | ||
1200.45.080 Boehringer Ingelheim Investigational Site | Brooklyn | New York | United States | Details | ||
1200.45.068 Boehringer Ingelheim Investigational Site | Fresh Meadows | New York | United States | Details | ||
1200.45.051 Boehringer Ingelheim Investigational Site | New York | New York | United States | Details | ||
1200.45.092 Boehringer Ingelheim Investigational Site | New York | New York | United States | Details | ||
1200.45.001 Boehringer Ingelheim Investigational Site | Charlotte | North Carolina | United States | Details | ||
1200.45.086 Boehringer Ingelheim Investigational Site | Bismarck | North Dakota | United States | Details | ||
1200.45.048 Boehringer Ingelheim Investigational Site | Minot | North Dakota | United States | Details | ||
1200.45.090 Boehringer Ingelheim Investigational Site | Canton | Ohio | United States | Details | ||
1200.45.005 Boehringer Ingelheim Investigational Site | Columbus | Ohio | United States | Details | ||
1200.45.089 Boehringer Ingelheim Investigational Site | Tulsa | Oklahoma | United States | Details | ||
1200.45.094 Boehringer Ingelheim Investigational Site | Portland | Oregon | United States | Details | ||
1200.45.020 Boehringer Ingelheim Investigational Site | Hershey | Pennsylvania | United States | Details | ||
1200.45.096 Boehringer Ingelheim Investigational Site | Johnstown | Pennsylvania | United States | Details | ||
1200.45.060 Boehringer Ingelheim Investigational Site | Philadelphia | Pennsylvania | United States | Details | ||
1200.45.085 Boehringer Ingelheim Investigational Site | Pottstown | Pennsylvania | United States | Details | ||
1200.45.120 Boehringer Ingelheim Investigational Site | Rapid City | South Dakota | United States | Details | ||
1200.45.049 Boehringer Ingelheim Investigational Site | Cookeville | Tennessee | United States | Details | ||
1200.45.113 Boehringer Ingelheim Investigational Site | El Paso | Texas | United States | Details | ||
1200.45.045 Boehringer Ingelheim Investigational Site | Fairfax | Virginia | United States | Details | ||
1200.45.076 Boehringer Ingelheim Investigational Site | Seattle | Washington | United States | Details | ||
1200.45.093 Boehringer Ingelheim Investigational Site | Charleston | West Virginia | United States | Details | ||
1200.45.125 Boehringer Ingelheim Investigational Site | Wausau | Wisconsin | United States | Details |